|
2022
|
Invention
|
1-antitrypsin deficiency. 111-antitrypsin deficiency (A1AD or AATD). |
|
|
Invention
|
Compounds and their use for the treatment of alpha1-antitrypsin deficiency. 144, m and n are as d... |
|
|
Invention
|
Compounds and their use for the treatment of alpha1-antitrypsin deficiency. 11-antitrypsin defici... |
|
|
Invention
|
Compounds and their use for the treatment of α1-antitrypsin deficiency. The invention relates to ... |
|
|
Invention
|
Compositions and their use for the treatment of α1-antitrypsin deficiency. 11-antitrypsin deficie... |
|
2021
|
Invention
|
Process for preparing n,n-dimethyl-4-((6-oxopyrimidin-1(6h)-yl)methyl)benzamide from 4-((6-oxopyr... |
|
|
Invention
|
4-((6-oxopyrimidin-1(6h)-yl)methyl)benzoic acid as an inducer of z a1 at secretion for treating a... |
|
2020
|
Invention
|
Compounds and their use for the treatment of .alpha.1-antitrypsin deficiency. The invention relat... |
|
|
Invention
|
Compounds and their use for the treatment of .alpha.1-antitrypsin deficiency. Compounds and their... |
|
|
Invention
|
1-antitrypsin deficiency. The invention relates to specified carboxylic acid compounds of formula... |
|
|
Invention
|
1-antitrypsin deficiency. The invention relates to specified benzamide compounds of formula (1), ... |
|
|
Invention
|
4-((2-oxopyri din-1 (2h)-yl)methyl)benzamides for treating alpha1 -antitrypsin deficiency. The in... |
|
|
Invention
|
Compounds and their use for the treatment of α1-antitrypsin deficiency. Compounds and their Use f... |
